Home › Kanser sa Prostate › Minnesota
Pag-aaral pangklinika para sa Kanser sa Prostate sa Minnesota
47 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Minnesota.
Mga Lungsod sa Minnesota
- Minneapolis22 pag-aaral
- Rochester20 pag-aaral
- Saint Paul14 pag-aaral
- Duluth7 pag-aaral
- Saint Cloud6 pag-aaral
- Bloomington6 pag-aaral
- Plymouth6 pag-aaral
- Brooklyn Park6 pag-aaral
Opisyal na teksto ng pag-aaral (English)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Minnesota Oncology - Burnsville, Burnsville
- Minnesota Oncology Hematology PA-Chaska, Chaska
- Mercy Hospital, Coon Rapids
- at 21 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 13, 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- Fairview Southdale Hospital, Edina
- at 9 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Rochester
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Nob 12, 2026 · NCT06511141The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- at 49 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Essentia Health Cancer Center, Duluth
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- University Of Minnesota, Minneapolis
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06095089Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
- United Hospital, Saint Paul
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT07200830Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06931340Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers
- University of Minnesota/Masonic Cancer Center, Minneapolis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Nob 2, 2026 · NCT07910019A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 30, 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 29, 2026 · NCT05519449A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06172478Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology Hematology PA-Chaska, Chaska
- at 16 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 121, Saint Paul
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05914116A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT07103018A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Avera Cancer Institute - Marshall ( Site 0122), Marshall
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
- HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT07213674A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Rochester
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 16, 2026 · NCT06879041Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Marshall
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 15, 2026 · NCT07711002Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Minneapolis
Nagre-recruitPhase 1/2
Edad 18 hanggang 99 · Kalalakihan · Na-update Okt 14, 2026 · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Rochester
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT06952803Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Mayo Clinic Health System-Mankato, Mankato
- Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT06325046Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Mercy Hospital, Coon Rapids
- Fairview Southdale Hospital, Edina
- Unity Hospital, Fridley
- at 6 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 8, 2026 · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05919264A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Okt 5, 2026 · NCT06990880Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- M Health Fairview Clinics and Surgery Center, Minneapolis
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT06801236Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 18, 2026 · NCT07650240Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Rochester, Rochester
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT06056830A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Masonic Cancer Center, Minneapolis
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 21, 2026 · NCT06844383Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Minnesota Urology, Woodbury
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kalalakihan · Na-update Ago 18, 2026 · NCT07455058MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
- Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 45 hanggang 80 · Kalalakihan · Na-update Hul 22, 2026 · NCT05438563Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Hul 20, 2026 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- at 18 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Minnesota Oncology Hematology, Minneapolis
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- at 2 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Mayo Clinic in Rochester, Rochester
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06788886Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Rochester, Rochester
Nagre-recruitPhase 4
Edad 18 hanggang 100 · Kalalakihan · Na-update Hun 4, 2026 · NCT05803941Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT07354919Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.